Mustea A - Search Results

1

Bevacizumab Combined with Platinum-Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients.

Sehouli J, Mustea A, Oskay-Özcelik G, Keller M, Richter R, Tomé O, Woopen H, Sommer-Joos AK, Grabowski JP, Armbrust R, Wimberger P. Sehouli J, et al. Among authors: mustea a. Cancers (Basel). 2021 Sep 22;13(19):4739. doi: 10.3390/cancers13194739. Cancers (Basel). 2021. PMID: 34638225 Free PMC article.

2

Interleukin-1 receptor antagonist gene polymorphism and cancer.

Sehouli J, Mustea A. Sehouli J, et al. Among authors: mustea a. Clin Infect Dis. 2002 Jun 1;34(11):1535-6. doi: 10.1086/340530. Clin Infect Dis. 2002. PMID: 12015703 No abstract available.

3

Polymorphism of IL-1 receptor antagonist gene: role in cancer.

Sehouli J, Mustea A, Könsgen D, Katsares I, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2002 Nov-Dec;22(6A):3421-4. Anticancer Res. 2002. PMID: 12530098 Review.

4

Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.

Mustea A, Sehouli J, Könsgen D, Stengel D, Sofroni D, Lichtenegger W. Mustea A, et al. Anticancer Res. 2003 Mar-Apr;23(2A):1099-102. Anticancer Res. 2003. PMID: 12820354

5

Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study.

Sehouli J, Akdogan Z, Heinze T, Könsgen D, Stengel D, Mustea A, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2003 Mar-Apr;23(2A):1115-8. Anticancer Res. 2003. PMID: 12820357

6

Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.

Sehouli J, Mustea A, Koensgen D, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1205-8. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652282

7

Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies.

Sehouli J, Könsgen D, Nimpsch R, Stengel D, Oskay G, Mustea A, Oertel J, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2003 Sep-Oct;23(5b):4133-40. Anticancer Res. 2003. PMID: 14666614

8

Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.

Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kühn W, Nehmzow M, Opri F, Klare P, Dietel M, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2004 Mar-Apr;24(2C):1223-9. Anticancer Res. 2004. PMID: 15154651 Free article.

9

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells.

Sun P, Sehouli J, Denkert C, Mustea A, Könsgen D, Koch I, Wei L, Lichtenegger W. Sun P, et al. Among authors: mustea a. J Mol Med (Berl). 2005 Jun;83(6):457-67. doi: 10.1007/s00109-005-0639-3. Epub 2005 Mar 16. J Mol Med (Berl). 2005. PMID: 15770498

10

Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

Chekerov R, Klaman I, Zafrakas M, Könsgen D, Mustea A, Petschke B, Lichtenegger W, Sehouli J, Dahl E. Chekerov R, et al. Among authors: mustea a. Neoplasia. 2006 Jan;8(1):38-45. doi: 10.1593/neo.05580. Neoplasia. 2006. PMID: 16533424 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters